The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer

British Journal of Cancer

Volumn 100, Issue 1, 2009, Pages 63-69

  Deans, D A C ^a   Tan, B H ^a   Wigmore, S J ^a   Ross, J A ^a   De Beaux, A C ^a   Paterson Brown, S ^a   Fearon, K C H ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cachexia; Inflammation; SIMS

Indexed keywords

ACUTE PHASE PROTEIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CONTROLLED STUDY; DIETARY INTAKE; DYSPHAGIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; WEIGHT REDUCTION;

ACUTE-PHASE PROTEINS; AGED; DEGLUTITION DISORDERS; EATING; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NUTRITIONAL STATUS; STOMACH NEOPLASMS; WEIGHT LOSS;

EID: 58149215987     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604828     Document Type: Article

References (39)

1. Alexandrakis MG, Passam FH, Ganotakis ES, Sfiridaki K, Xilouri I, Perisinakis K (2003) The clinical and prognostic significance of erythrocyte sedimentation rate, serum inteleukin-6 and acute phase protein levels in multiple myeloma. Clin Lab Haematol 25(1): 41-46
2. Argiles JM, Alvarez B, Lopez-Soriano FJ (1997) The metabolic basis of cancer cachexia. Med Res Rev 17(5): 477-498
3. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL (2003) Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 308(10): 553-558
4. Barber MD, Fearon KCH, McMillan DC, Slater C, Ross JA, Preston T (2000) Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. Am J Physiol Endocrinol Metab 279(3): E707-E714
5. Barber MD, Powell JJ, Lynch SF, Gough NJ, Fearon KCH, Ross JA (1999a) Two polymorphisms of the tumour necrosis factor gene do not influence survival in pancreatic cancer. Clin Exp Immunol 117: 425-429a
6. Barber MD, Ross JA, Fearon KCH (1999b) Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35(2): 106-110
7. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15: 74-80
8. Bingham S, Wiggins HS, Englyst H, Seppanen R, Helms P, Strand R (1982) Methods and validity of dietary assessments in four Scandinavian populations. Nutr Cancer 4: 23-33
9. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5(6): 1369-1379
10. Crozier JE, McMillan DC, McArdle CS, Angerson WJ, Anderson JH, Horgan PG, McKee RF (2007) Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol 22(12): 2288-2291
11. Deans DAC, Wigmore SJ, de Beaux AC, Paterson-Brown S, Garden OJ, Fearon KCH (2007) Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. BJS 94: 1501-1509
12. Department of Health (1991) Dietary reference values for food, energy and nutrients for the United Kingdom. 41. HMSO
13. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69(4): 491-497
14. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC (1994) Cytokines, the acute phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 219(4): 325-331
15. Falconer JS, Fearon KCH, Ross JA, Elton R, Wigmore SJ, Garden OJ, Carter DC (1995) Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer 75(8): 2077-2082
16. Fearon KC (2008) Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8): 1124-1132
17. Fearon KCH, von Meyenfeldt MF, Moses AG, van Greenan R, Roy A, Gouma DJ (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10): 1479-1486
18. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, Ledingham IM (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1: 781-784
19. Gabay C, Kushner I (1999) Acute phase proteins and other systemic responses to inflammation. N Engl J Med 340(6): 448-454
20. Galizia G, Lieto E, De Vita F, Romano C, Orditura M, Castellano P (2002) Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. J Interferon Cytokine Res 22(4): 473-482
21. Gelin J, Moldawer LL, Lonnroth C, Sherry B, Chizzonite R, Lundholm K (1991) Role of endogenous TNFα and IL-1 for experimental tumour growth and the development of cancer cachexia. Cancer Res 51(1): 415-421
22. Gibson R (1990) Principles of Nutritional Assessment. Oxford University Press: Oxford
23. Inagaki J, Rodriguez V, Bodey GP (1974) Causes of death in cancer patients. Cancer 33: 568-573
24. Kelson DP, Ginsberg R, Pajak T, Sheahan DG, Gunderson L, Mortimer J (1998) Chemotherapy followed by surgery compared with surgery alone for localised oesophageal cancer. N Engl J Med 339: 1979-1984
25. Knyrim K, Wagner H, Bethge N, Keymling M, Vakil N (1993) A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329(18): 1302-1307
26. Lamb GW, McMillan DC, Ramsey S, Aitchison M (2006) The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer 94(6): 781-784
27. Martignoni ME, Kunze P, Hildebrandt W, Kunzli B, Berberat P, Giese T (2005) Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 11: 5802-5808
28. McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC (2008) The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer. Br J Cancer 98(5): 888-893
29. O'Gorman P, McMillan DC, McArdle CS (1999) Longitudinal study of weight, appetite, performance status and inflammation in advanced gastrointestinal cancer. Nutr Cancer 35(2): 127-130
30. Preston T, Slater C, McMillan DC, Falconer JS, Shenkin A, Fearon KC (1998) Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 128(8): 1355-1360
31. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien ME (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90(10): 1905-1911
32. Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, Milroy R (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87(3): 264-267
33. Selby P, Hobbs S, Viner C, Jackson E, Jones A, Newall D (1987) Tumour necrosis factor in man: clinical and biological observations. Br J Cancer 56: 803-808
34. Stouthard JML, Romijn JA, van der Poll T, Endert E, Klein S, Bakker PJM (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268: E813-E819
35. Strassmann G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89(5): 1681-1684
36. Studley HD (1936) Percentage of weight loss. A basic indicator of surgical risk in patients with chronic peptic ulcer disease. JAMA 106: 458-460
37. Tamakoshi K, Yatsuya H, Kondo T, Hirano T, Hori Y, Yoshida T, Toyoshima H (2003) The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obesity 27: 247-252
38. Wigmore SJ, Fearon KCH, Lai PBS, O'Riordain MG, Falconer JS, Maingay JP, Ross JA (1997) Recombinant and tumour-cell derived IL-8 stimulates acute phase protein production by isolated human hepatocytes. Am J Physiol 273: E720-E726
39. Wigmore SJ, Fearon KCH, Sangster K, Maingay JP, Garden OJ, Ross JA (2002) Cytokine regulation of constitutive production of IL-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int J Oncol 21(4): 881-886